– USA, NV – Black Cactus Global (OTCQB:BLGI) is pleased to announce that Dr Kancherla Pruthvinath and Dr Ramesh Para have joined the Board of Directors.
Dr. Pruthvinath is a medical doctor and holds a Master’s Degree in Hospital Administration with a concentration in technology and cyber security. He is Director of Gleneagles Global Hospitals Group of India, which operates multi-organ transplant facilities in four major metropolitan areas in India.
Dr. Para holds a Ph.D. in Management Information Systems as well as an MBA. He is Director of Sysveda UK Limited, an information sciences consultancy where he has led projects in Systems Development, Technical Architecture, Data Engineering and Distributed Applications for such noteworthy companies as Nomura Asset Management UK, HSBC Global, SAS and AmEx UK.
Harp Sangha, Chairman of Black Cactus Global, commented, “Kancherla’s set of skills and expertise are well suited to our plans for bringing Blockchain applications for streamlining administrative processes and delivering hyper secure solutions to the healthcare field, and I am elated to have Ramesh on our Board. His expertise in complex Information systems will be a significant addition to our team of experts as well as a substantial attraction for business opportunities.”
About Black Cactus Global
Black Cactus Global is a technology development company with a focus on Blockchain, machine learning, cryptocurrency, and the Internet of Things. We partner with international government agencies, large corporations and specialised groups on global development and consulting projects in our key development areas of Fintech, digital media, financial services, cyber security, and healthcare.
Our mission is to pioneer the application of Blockchain and overlapping technologies to protect IP and the security of data and financial transactions.
For more information : http://www.blackcactusglobal.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.